Skip to content

600436.SH

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

SSE · Healthcare · Drug Manufacturers - General · CN

CNY 127.73
−0.34%
Ask drillr

Year over year

Reported trailing growth

Revenue
-20.1%
EBITDA
—
EBIT
-37.6%
EPS
-36.7%
Free cash flow
-89.3%
Operating cash flow
-73.4%

Forward estimates

Based on analyst estimates

Revenue
-11.9%
EBITDA
+2.1%
EPS
+11.7%

Three-year CAGR

Revenue
+1.2%
EBITDA
-4.6%
EBIT
-5.1%
Net income
-4.4%
EPS
-4.4%
Free cash flow
—

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026